{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study discusses mutations in PINK1 and their association with recessive parkinsonism, suggesting a loss of function mechanism.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to loss of function of the PINK1 protein, which is relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses in vitro kinase assays and cellular assays to assess the effects of mutations on PINK1 kinase activity and protein stability.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis/mechanism by assessing the impact of mutations on the kinase activity and stability of PINK1, which are key to understanding the loss of function in parkinsonism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The study includes appropriate controls and replicates, and uses established methods for assessing kinase activity and protein stability."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_4a": {
            "step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "The study uses ANOVA with Fisher’s PLSD post hoc test for statistical analysis of the effects of mutations on kinase activity.",
            "judgment": "Yes",
            "reasoning": "The statistical analyses provided in the paper are sufficient to estimate the effects of the G309D mutation on the functional activity of PINK1.",
            "next_step_or_outcome": "Proceed to Sub-step 4c"
          },
          "sub_step_4c": {
            "step_name": "Sub-step 4c: Correlate OddsPath",
            "extracted_paper_info": "The study reports that G309D has somewhat decreased activity (60.5% of wild type; P < 0.01).",
            "judgment": "Yes",
            "reasoning": "The decrease in activity, while statistically significant, is modest, suggesting a moderate effect on the functional activity of PINK1.",
            "next_step_or_outcome": "PS3_moderate"
          }
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The G309D variant in PINK1 shows a moderate decrease in kinase activity, which is statistically significant but less dramatic compared to other mutations. This suggests a moderate supporting evidence for pathogenicity."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study discusses mutations in PINK1 and their association with recessive parkinsonism, suggesting a loss of function mechanism.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to loss of function of the PINK1 protein, which is relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses in vitro kinase assays and cellular assays to assess the effects of mutations on PINK1 kinase activity and protein stability.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis/mechanism by assessing the impact of mutations on the kinase activity and stability of PINK1, which are key to understanding the loss of function in parkinsonism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The study includes appropriate controls and replicates, and uses established methods for assessing kinase activity and protein stability."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_4a": {
            "step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "The study uses ANOVA with Fisher’s PLSD post hoc test for statistical analysis of the effects of mutations on kinase activity.",
            "judgment": "Yes",
            "reasoning": "The statistical analyses provided in the paper are sufficient to estimate the effects of the L347P mutation on the functional activity of PINK1.",
            "next_step_or_outcome": "Proceed to Sub-step 4c"
          },
          "sub_step_4c": {
            "step_name": "Sub-step 4c: Correlate OddsPath",
            "extracted_paper_info": "The study reports that L347P had drastically decreased activity (<10% of wild type).",
            "judgment": "Yes",
            "reasoning": "The drastic decrease in activity suggests a very strong effect on the functional activity of PINK1.",
            "next_step_or_outcome": "PS3_very_strong"
          }
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The L347P variant in PINK1 results in a very strong decrease in kinase activity, indicating a significant loss of function, which supports a pathogenic role for this variant."
    }
  ]
}